OPEN END TURBO LONG - MERCK & CO. | Real-time Bid/Ask 05:32:14 03/06/2024 pm IST | ||
| 3.5 EUR / 3.6 EUR | +1.14% |
|
| 1 month | -12.47% | ||
| 3 months | -9.54% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 3.51 | 0.00% |
| 31/24/31 | 3.51 | +0.86% |
| 30/24/30 | 3.48 | -3.33% |
| 29/24/29 | 3.6 | +0.28% |
| 28/24/28 | 3.59 | -7.47% |
Delayed Quote Börse Stuttgart
Last update June 03, 2024 at 03:46 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MD330H |
| ISIN | DE000MD330H8 |
| Date issued | 31/03/2022 |
| Strike | 87.29 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.52 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.34 € |
|---|---|
| Lowest since issue | 0.57 € |
| Spread | 0.1 € |
| Spread % | 2.78% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Certificates
- Certificat
